These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 868966)

  • 21. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal neoplasia and dysplasia. II. Retinoblastoma occurring with persistence and hyperplasia of the primary vitreous.
    Irvine AR; Albert DM; Sang DN
    Invest Ophthalmol Vis Sci; 1977 May; 16(5):403-7. PubMed ID: 852942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors.
    Gimbrone MA; Leapman SB; Cotran RS; Folkman J
    J Natl Cancer Inst; 1973 Jan; 50(1):219-28. PubMed ID: 4692862
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-induced angiogenesis: lack of inhibition by irradiation.
    Auerbach R; Arensman R; Kubai L; Folkman J
    Int J Cancer; 1975 Feb; 15(2):241-5. PubMed ID: 1126757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
    Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.
    Taylor CM; Kissun RD; Schor AM; McLeod D; Garner A; Weiss JB
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2174-8. PubMed ID: 2477343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
    Kamei M; Misono K; Lewis H
    Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rabbit rubeosis iridis induced by intravitreal latex-derived angiogenic fraction.
    Paula JS; Ribeiro VR; Sampaio RB; Mendonca RJ; Haddad A; Tedesco AC; Coutinho-Netto J; Haendchen HA; Jorge R
    Curr Eye Res; 2011 Sep; 36(9):857-9. PubMed ID: 21599469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
    Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental ocular angiogenesis.
    Federman JL; Brown GC; Felberg NT; Felton SM
    Am J Ophthalmol; 1980 Feb; 89(2):231-7. PubMed ID: 6153510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor angiogensis: role in regulation of tumor growth.
    Folkman J
    Symp Soc Dev Biol; 1974; 30(0):43-52. PubMed ID: 4600889
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of tumor angiogenesis factor in adenocarcinoma of kidney.
    Bard RH; Mydlo JH; Freed SZ
    Urology; 1986 May; 27(5):447-50. PubMed ID: 2422803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
    You JJ; Yang CH; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A morphological study of experimental intravitreal proliferative tissues].
    Sano T; Yamane A; Tokura T; Miki H
    Nippon Ganka Gakkai Zasshi; 1991 Feb; 95(2):140-6. PubMed ID: 1711280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
    Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.